This is the first time that two scFvs have been used in combinationin vivo, revealing a novel application for full antibodies or antibody fragments. more effective than targeting a single epitope. Overall, we demonstrate the feasibility of usingDrosophilaas a first step for characterizing neuroprotective anti-A scFvsin vivoand identifying scFv mixtures with synergistic neuroprotective activities. == […]